INTERVIEWS

Tzvia Bader, co-founder, and CEO talks about TrialJectory, a first-of-its-kind AI-powered platform that uses self-reported clinical data to match cancer patients with clinical trials and removes barriers to advanced treatment options.  Tzvia is a cancer survivor and knows first hand what it’s like to be in search of the right clinical study. This service will allow all patients, regardless of where they are or their income level, to have access to the most up-to-date treatments.

Matthew Bauer, L.Ac., President at The Acupuncture Now Foundation, a non-profit organization discusses the practice of acupuncture, the foundation, and their mission to bring accurate up to date information and resources to health professionals and the public.  He also talks about how acupuncture works with mainstream medicine.

Alison Corcoran, EVP and Chief Marketing Officer at DentaQuest, discusses the gaps in dental care in the U.S., the future of oral health in this country, and what can be done to change a system that is failing millions of Americans.

Theresa (Terry) Hush, CEO of Roji Health Intelligence, a company that is helping to improve the quality of healthcare by enabling better decisions through integrated data, discusses her mission to give doctors/healthcare providers the right information to make smarter patient decisions while reducing healthcare costs.  She also talks about why patient experience needs to move beyond convenience and responsiveness.

Roughly 75% of the earth’s surface is covered by water, yet the ocean remains largely unexplored for drug discovery.  Gloucester Marine Genomics Institute (GMGI) scientists are excited to lead the charge in exploring the ocean’s microbiome to provide research to inform treatments – possibly cures – of devastating diseases.  Dr. Andrea Bodnar is here to talk about some of the latest marine research and its look at anti-ageing and human health effects.

Dr. John Albert, a rheumatologist at the Rheumatic Disease Center in southeastern Wisconsin, discusses a new in-practice patient series presented at the American College of Rheumatology (ACR) Annual Meeting 2019. The series looked at how methotrexate may attenuate the immune response to KRYSTEXXA to allow more patients on KRYSTEXXA to continue their treatment, helping to inform rheumatologists on effective treatment practices to control the serious and chronic disease of gout.

Dr. William (Bill) Dalton, founder and executive chair of the board at M2Gen, a health informatics solutions company discusses the partnership with the Oncology Research Information Exchange Network® (ORIEN), a national network of leading cancer centers that exchange research and clinical data that is advancing the care of patients and accelerating the discovery and development of medicines to treat them. He also discusses Total Cancer Care®, the world’s largest prospective research study in cancer where patients donate clinical data and tissue to help researchers.

Dr. Kristen Hurley, MPH, PhD, Senior Vice President of Nutrition at Vitamin Angels; and assistant professor at  Johns Hopkins Bloomberg School of Public Health, discusses Vitamin Angels’ new partnership with the Gates Foundation to connect more pregnant women around the world with prenatal vitamins.  Though most countries offer some level of nutritional aid to pregnant women in need, millions of women worldwide do not have access to prenatal multivitamins. Dr. Hurley is working to close that gap.

Dr. David Stern, CEO of Experity discusses his role and the company’s role in driving innovation in on-demand care in the urgent care space.  He also talks about going from practicing physician to CEO of the leader in on-demand technology.

Remington Walls, a 19-year-old sophomore at Valdosta State University in GA talks about living with a chronic, allergic inflammatory disease known as eosinophilic esophagitis (EoE) and can only consume nutritional formulas.